Table 3.
Quality assessment of included studies.
RCTs | 1 | 2 | 3 | 4 | 5 | The overall risk of bias | |||
---|---|---|---|---|---|---|---|---|---|
Dong et al. (22) | ** | ** | * | * | ** | ** | |||
Harber et al. (24) | ** | ** | * | * | ** | ** | |||
Neunhäuserer et al. (23) | ** | ** | * | * | * | ** | |||
Non-RCTs | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
Just et al. (25) | *** | ** | ** | * | * | * | ** | * | ** |
Kyung et al. (15) | *** | ** | * | * | ** | * | ** | * | ** |
Samannan et al. (26) | *** | ** | * | * | ** | * | * | * | ** |
1. Randomization process; 2. Deviation from intended intervention; 3. Missing outcome data; 4. Measurement of outcome; 5. Selection of reported results. *, Low risk; **, Some concerns; ***, High risk.
1. Random sequence generation; 2. Allocation concealment; 3. Baseline outcome measurements similar; 4. Baseline characteristics similar; 5. Incomplete outcome data; 6. Knowledge of the allocated interventions adequately prevented during the study; 7. Protection against contamination; 8. Selective outcome reporting; 9. Other risks of bias.
*, Low risk; **, Unclear; ***, High risk.